Healthcare -
Biotechnology - NASDAQ - US
$ 3.94
2.07 %
$ 278 M
Market Cap
-2.42
P/E
CCCC - OPERATING EXPENSES
Operating Expenses CCCC - C4 Therapeutics, Inc.
160 M
LAST VALUE
11.76%
2 YEAR CAGR
34.91%
5 YEAR CAGR
0.00%
10 YEAR CAGR